BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

187 related articles for article (PubMed ID: 16925019)

  • 1. Minigene reporter for identification and analysis of cis elements and trans factors affecting pre-mRNA splicing.
    Singh G; Cooper TA
    Biotechniques; 2006 Aug; 41(2):177-81. PubMed ID: 16925019
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Use of minigene systems to dissect alternative splicing elements.
    Cooper TA
    Methods; 2005 Dec; 37(4):331-40. PubMed ID: 16314262
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Cis-acting intronic elements that regulate cartilage-specific alternative splicing of the type II collagen (Col2) pre-mRNA lie at or near splice site junction sequences flanking exon 2 of the gene.
    Nishiyama T; Hatano H; Kurosaka M; Bolander ME; Sarkar G
    J Bone Miner Res; 2003 Sep; 18(9):1716-22. PubMed ID: 12968682
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Genome-wide prediction of cis-acting RNA elements regulating tissue-specific pre-mRNA alternative splicing.
    Wang X; Wang K; Radovich M; Wang Y; Wang G; Feng W; Sanford JR; Liu Y
    BMC Genomics; 2009 Jul; 10 Suppl 1(Suppl 1):S4. PubMed ID: 19594881
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Identification of cis-acting elements involved in acetylcholinesterase RNA alternative splicing.
    Guerra M; Dobbertin A; Legay C
    Mol Cell Neurosci; 2008 May; 38(1):1-14. PubMed ID: 18313329
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Characterization of cis-acting elements that control oscillating alternative splicing.
    Goldammer G; Neumann A; Strauch M; Müller-McNicoll M; Heyd F; Preußner M
    RNA Biol; 2018; 15(8):1081-1092. PubMed ID: 30200840
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Defective pre-mRNA splicing in PKD1 due to presumed missense and synonymous mutations causing autosomal dominant polycystic disease.
    Gonzalez-Paredes FJ; Ramos-Trujillo E; Claverie-Martin F
    Gene; 2014 Aug; 546(2):243-9. PubMed ID: 24907393
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Mechanisms and Regulation of Alternative Pre-mRNA Splicing.
    Lee Y; Rio DC
    Annu Rev Biochem; 2015; 84():291-323. PubMed ID: 25784052
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Structural determinants for alternative splicing regulation of the MAPT pre-mRNA.
    Lisowiec J; Magner D; Kierzek E; Lenartowicz E; Kierzek R
    RNA Biol; 2015; 12(3):330-42. PubMed ID: 25826665
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Cell-based splicing of minigenes.
    Smith SA; Lynch KW
    Methods Mol Biol; 2014; 1126():243-55. PubMed ID: 24549669
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Analysis of mutations that influence pre-mRNA splicing.
    Zhang Z; Stamm S
    Methods Mol Biol; 2011; 703():137-60. PubMed ID: 21125488
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Identification of a cis-acting element involved in the regulation of BACE1 mRNA alternative splicing.
    Mowrer KR; Wolfe MS
    J Neurochem; 2009 May; 109(4):1008-16. PubMed ID: 19302194
    [TBL] [Abstract][Full Text] [Related]  

  • 13. IRAS: High-Throughput Identification of Novel Alternative Splicing Regulators.
    Zheng S
    Methods Enzymol; 2016; 572():269-89. PubMed ID: 27241759
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Identification of an intronic splicing regulatory element involved in auto-regulation of alternative splicing of SCL33 pre-mRNA.
    Thomas J; Palusa SG; Prasad KV; Ali GS; Surabhi GK; Ben-Hur A; Abdel-Ghany SE; Reddy AS
    Plant J; 2012 Dec; 72(6):935-46. PubMed ID: 22913769
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Identification of RNA-binding proteins that regulate FGFR2 splicing through the use of sensitive and specific dual color fluorescence minigene assays.
    Newman EA; Muh SJ; Hovhannisyan RH; Warzecha CC; Jones RB; McKeehan WL; Carstens RP
    RNA; 2006 Jun; 12(6):1129-41. PubMed ID: 16603716
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Finding signals that regulate alternative splicing in the post-genomic era.
    Ladd AN; Cooper TA
    Genome Biol; 2002 Oct; 3(11):reviews0008. PubMed ID: 12429065
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Splicing in disease: disruption of the splicing code and the decoding machinery.
    Wang GS; Cooper TA
    Nat Rev Genet; 2007 Oct; 8(10):749-61. PubMed ID: 17726481
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Use of RNA interference to dissect the roles of trans-acting factors in alternative pre-mRNA splicing.
    Park JW; Graveley BR
    Methods; 2005 Dec; 37(4):341-4. PubMed ID: 16314263
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Dynamic fluorescent and luminescent reporters for cell-based splicing screens.
    Warzecha CC; Hovhannisyan R; Carstens RP
    Methods Mol Biol; 2012; 867():273-87. PubMed ID: 22454068
    [TBL] [Abstract][Full Text] [Related]  

  • 20. cis-Acting and trans-acting modulation of equine infectious anemia virus alternative RNA splicing.
    Liao HJ; Baker CC; Princler GL; Derse D
    Virology; 2004 May; 323(1):131-40. PubMed ID: 15165825
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 10.